Comparison · NCT01795833-bf94b72f
Text Messages vs Control: Number of Participants With Progression to Type 2 Diabetes
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Text Messages vs Control: Number of Participants With Progression to Type 2 Diabetes. Trial comparisons, record NCT01795833-bf94b72f. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01795833-bf94b72f
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.21 | 0.186 | 0.235 | wilson | |
| Risk in group 2 | 0.227 | 0.202 | 0.254 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0175 | -0.0531 | 0.0182 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.923 | 0.784 | 1.09 | log | |
| Odds ratio, group 1 over group 2 | 0.903 | 0.732 | 1.11 | log | |
| Number needed to treat, for one fewer participant with the outcome on Text Messages than on Control | 57.3 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Text Messages | Short text messages related to healthy lifestyle will be sent to half the subjects three times per week, in addition to one off 'one-to-one structured education' during the study period.~Short text messages: In addition to structured education on healthy lifestyle provided at baseline, subjects in the arm will receive short text messages containing educational, motivational and supportive content on diet, physical activity, and smoking (if appropriate) during the study period. The content will be appropriate to the stage of the transtheoretical model of behavioural change that the subject is in. This will be assessed by questionnaire at each visit to clinic. | 216 | 1,031 | OG000 |
| Group 2 | Control | Half of the subjects who has received only one off 'one-to-one structured education about healthy lifestyle during the study period | 234 | 1,031 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Number of Participants With Progression to Type 2 Diabetes
- Description
The primary outcome will be progression to type 2 diabetes as measured by HbA1c at baseline, 6 months, 12 months and 24 months or by any validated criteria in any other care setting. the World health Organization (WHO) / International Diabetes Federation (IDF) criteria for diagnosis of diabetes will be used throughout.
- Time frame
- 24 months
- Population
Source ClinicalTrials.gov
Trial
- Title
- Diabetes Prevention Using SMS Technology
- NCT number
- NCT01795833
- Phases
- NA
- Conditions
- Prediabetes
- Interventions
- Short text messages
- Lead sponsor
- Imperial College London
- Results first posted
- 2019-11-12
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01795833?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01795833-bf94b72f